Literature DB >> 34120768

Autophagy in liver diseases: A review.

Hui Qian1, Xiaojuan Chao1, Jessica Williams1, Sam Fulte1, Tiangang Li2, Ling Yang3, Wen-Xing Ding4.   

Abstract

The liver is a highly dynamic metabolic organ that plays critical roles in plasma protein synthesis, gluconeogenesis and glycogen storage, cholesterol metabolism and bile acid synthesis as well as drug/xenobiotic metabolism and detoxification. Research from the past decades indicate that autophagy, the cellular catabolic process mediated by lysosomes, plays an important role in maintaining cellular and metabolic homeostasis in the liver. Hepatic autophagy fluctuates with hormonal cues and the availability of nutrients that respond to fed and fasting states as well as circadian activities. Dysfunction of autophagy in liver parenchymal and non-parenchymal cells can lead to various liver diseases including non-alcoholic fatty liver diseases, alcohol associated liver disease, drug-induced liver injury, cholestasis, viral hepatitis and hepatocellular carcinoma. Therefore, targeting autophagy may be a potential strategy for treating these various liver diseases. In this review, we will discuss the current progress on the understanding of autophagy in liver physiology. We will also discuss several forms of selective autophagy in the liver and the molecular signaling pathways in regulating autophagy of different cell types and their implications in various liver diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AALD; DILI; HCC; Lipophagy; Mitophagy; NAFLD

Mesh:

Year:  2021        PMID: 34120768      PMCID: PMC9585624          DOI: 10.1016/j.mam.2021.100973

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  323 in total

1.  Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.

Authors:  Fiorenza Fumagalli; Julia Noack; Timothy J Bergmann; Eduardo Cebollero; Giorgia Brambilla Pisoni; Elisa Fasana; Ilaria Fregno; Carmela Galli; Marisa Loi; Tatiana Soldà; Rocco D'Antuono; Andrea Raimondi; Martin Jung; Armin Melnyk; Stefan Schorr; Anne Schreiber; Luca Simonelli; Luca Varani; Caroline Wilson-Zbinden; Oliver Zerbe; Kay Hofmann; Matthias Peter; Manfredo Quadroni; Richard Zimmermann; Maurizio Molinari
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

2.  Autophagic vacuoles in heart muscle and liver. A comparative morphometric study including circadian variations in meal-fed rats.

Authors:  U Pfeifer; P Strauss
Journal:  J Mol Cell Cardiol       Date:  1981-01       Impact factor: 5.000

3.  Elimination of excess smooth endoplasmic reticulum after phenobarbital administration.

Authors:  D Feldman; R L Swarm; J Becker
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

4.  Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival.

Authors:  Wen-Xing Ding; Hong-Min Ni; Wentao Gao; Yi-Feng Hou; Melissa A Melan; Xiaoyun Chen; Donna B Stolz; Zhi-Ming Shao; Xiao-Ming Yin
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

5.  Intrinsically Disordered Protein TEX264 Mediates ER-phagy.

Authors:  Haruka Chino; Tomohisa Hatta; Tohru Natsume; Noboru Mizushima
Journal:  Mol Cell       Date:  2019-04-18       Impact factor: 17.970

6.  Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease.

Authors:  Yuka Fukuo; Shunhei Yamashina; Hiroshi Sonoue; Atsushi Arakawa; Eisuke Nakadera; Tomonori Aoyama; Akira Uchiyama; Kazuyoshi Kon; Kenichi Ikejima; Sumio Watanabe
Journal:  Hepatol Res       Date:  2014-02-17       Impact factor: 4.288

7.  Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity.

Authors:  Mitchell R McGill; C David Williams; Yuchao Xie; Anup Ramachandran; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-23       Impact factor: 4.219

Review 8.  Therapeutic targets in liver fibrosis.

Authors:  Jonathan A Fallowfield
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-13       Impact factor: 4.052

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

10.  Transmembrane phospholipid translocation mediated by Atg9 is involved in autophagosome formation.

Authors:  Minami Orii; Takuma Tsuji; Yuta Ogasawara; Toyoshi Fujimoto
Journal:  J Cell Biol       Date:  2021-03-01       Impact factor: 10.539

View more
  13 in total

Review 1.  Role of mechanistic target of rapamycin in autophagy and alcohol-associated liver disease.

Authors:  Xiaojuan Chao; Sha Neisha Williams; Wen-Xing Ding
Journal:  Am J Physiol Cell Physiol       Date:  2022-09-05       Impact factor: 5.282

2.  Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy.

Authors:  Chuanbin Yang; Chengfu Su; Ashok Iyaswamy; Senthil Kumar Krishnamoorthi; Zhou Zhu; Sichang Yang; Benjamin Chunkit Tong; Jia Liu; Sravan G Sreenivasmurthy; Xinjie Guan; Yuxuan Kan; Aston Jiaxi Wu; Alexis Shiying Huang; Jieqiong Tan; Kingho Cheung; Juxian Song; Min Li
Journal:  Acta Pharm Sin B       Date:  2022-02-03       Impact factor: 14.903

Review 3.  Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls.

Authors:  Hartmut Jaeschke; Olamide B Adelusi; Jephte Y Akakpo; Nga T Nguyen; Giselle Sanchez-Guerrero; David S Umbaugh; Wen-Xing Ding; Anup Ramachandran
Journal:  Acta Pharm Sin B       Date:  2021-09-30       Impact factor: 11.413

4.  miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2.

Authors:  Ran Cheng; Hao Xu; Yang Hong
Journal:  Mol Med Rep       Date:  2021-09-09       Impact factor: 2.952

5.  Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.

Authors:  Adele D'Amico; Antonella Longo; Fabiana Fattori; Michele Tosi; Luca Bosco; Maria Beatrice Chiarini Testa; Maria Giovanna Paglietti; Claudio Cherchi; Adelina Carlesi; Irene Mizzoni; Enrico Bertini
Journal:  Orphanet J Rare Dis       Date:  2021-10-12       Impact factor: 4.123

6.  2-Amino-3-Methylimidazo[4,5-f]quinoline Triggering Liver Damage by Inhibiting Autophagy and Inducing Endoplasmic Reticulum Stress in Zebrafish (Danio rerio).

Authors:  Dan Li; Zhi Li; Tianchang Zhang; Bo Peng; Yan Zhang; Hongwen Sun; Shuo Wang
Journal:  Toxins (Basel)       Date:  2021-11-22       Impact factor: 4.546

Review 7.  Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.

Authors:  Wei Zhang; Chengchao Xu; Jichao Sun; Han-Ming Shen; Jigang Wang; Chuanbin Yang
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

8.  HtrA2/Omi mitigates NAFLD in high-fat-fed mice by ameliorating mitochondrial dysfunction and restoring autophagic flux.

Authors:  Wei Zhou; Xueting Deng; Xiaolei Zhu; Qinhui Yan; Nan Zhou; Susu Du; Xiaonan Li
Journal:  Cell Death Discov       Date:  2022-04-21

9.  Linking of Senescence to Autophagy Deficiency in Chronic Liver Disease.

Authors:  Xiaowen Ma; Sha Neisha Williams; Wen-Xing Ding
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-05-20

10.  FXR deficiency in hepatocytes disrupts the bile acid homeostasis and inhibits autophagy to promote liver injury in Schistosoma japonicum-infected mice.

Authors:  Beibei Zhang; Jing Li; Xianlong Zong; Jianling Wang; Lianlian Xin; Haiyao Song; Wenxue Zhang; Stephane Koda; Hui Hua; Bo Zhang; Qian Yu; Kui-Yang Zheng; Chao Yan
Journal:  PLoS Negl Trop Dis       Date:  2022-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.